Cizzle Biotechnology strengthens North American rollout of CIZ1B lung cancer test (LON:CIZ) 2 October 2025
Ilika CEO Graeme Purdy on PRIMED programme with JLR and Oxford University (LON:IKA) 25 September 2025
Roquefort Therapeutics secures exclusivity with Coiled Therapeutics RTO, eyeing AIM relist and NASDAQ (Video)
ICFG Ltd: Interim CEO Enkhmaral Batkhuyag Charts Bold Expansion with AI-Driven Finance and Insurtech Moves (Video)
Chinese tech stocks gain momentum amid shifting AI landscape | Ruffer Investment Company 21 November 2025
Latest Research: Fidelity Emerging Markets doubles benchmark’s performance over 12 months 12 November 2025
Clarkson PLC (CKN.L) Stock Analysis: Navigating Potential Upside with Robust Buy Ratings 19 November 2025
CMC Markets PLC (CMCX.L) Stock Analysis: Evaluating a 35.63% Potential Upside Amid Market Challenges 19 November 2025
Chrysalis Investments Limited (CHRY.L) Investor Outlook: Analyzing a 19% Potential Upside 19 November 2025
Cizzle Biotechnology strengthens North American rollout of CIZ1B lung cancer test (LON:CIZ) 2 October 2025
Ilika CEO Graeme Purdy on PRIMED programme with JLR and Oxford University (LON:IKA) 25 September 2025
Roquefort Therapeutics secures exclusivity with Coiled Therapeutics RTO, eyeing AIM relist and NASDAQ (Video)
ICFG Ltd: Interim CEO Enkhmaral Batkhuyag Charts Bold Expansion with AI-Driven Finance and Insurtech Moves (Video)
Chinese tech stocks gain momentum amid shifting AI landscape | Ruffer Investment Company 21 November 2025
Latest Research: Fidelity Emerging Markets doubles benchmark’s performance over 12 months 12 November 2025
Clarkson PLC (CKN.L) Stock Analysis: Navigating Potential Upside with Robust Buy Ratings 19 November 2025
CMC Markets PLC (CMCX.L) Stock Analysis: Evaluating a 35.63% Potential Upside Amid Market Challenges 19 November 2025
Chrysalis Investments Limited (CHRY.L) Investor Outlook: Analyzing a 19% Potential Upside 19 November 2025
CentralNic Group Analyst Q&A “diversification and better competitive advantages within the monetisation market (LON:CNIC) 18 September 2020
CentralNic Group “Codewise acquisition could raise monetisation market share to 37%” says Zeus Capital 14 September 2020
CentralNic Investor Presentation Sept 2020 – Building a better global digital economy 4 September 2020
CentralNic Group deliver ‘very satisfying numbers this year’ CEO Ben Crawford (Interview) 2 September 2020
CentralNic Group outstanding results, revenues up 124%, gross profit up 78%, Adjusted EBITDA up 64% 1 September 2020
CentralNic Group metrics highly attractive says Zeus Analyst Bob Liao (Analyst Interview) 13 August 2020
Roquefort Therapeutics secures exclusivity with Coiled Therapeutics RTO, eyeing AIM relist and NASDAQ (Video) 11 September 2025
ICFG Ltd: Interim CEO Enkhmaral Batkhuyag Charts Bold Expansion with AI-Driven Finance and Insurtech Moves (Video) 10 September 2025
Likewise Group: Scaling Fast with Sales Growth, Dividends and Distribution Muscle (Video) 10 September 2025
Cerillion Plc Gartner Magic Quadrant Recognition and the AI Edge Telcos Cannot Ignore 9 September 2025
Cizzle Biotechnology strengthens North American rollout of CIZ1B lung cancer test (LON:CIZ) 2 October 2025
Ilika CEO Graeme Purdy on PRIMED programme with JLR and Oxford University (LON:IKA) 25 September 2025
Chinese tech stocks gain momentum amid shifting AI landscape | Ruffer Investment Company 21 November 2025
Latest Research: Fidelity Emerging Markets doubles benchmark’s performance over 12 months 12 November 2025
Clarkson PLC (CKN.L) Stock Analysis: Navigating Potential Upside with Robust Buy Ratings 19 November 2025
CMC Markets PLC (CMCX.L) Stock Analysis: Evaluating a 35.63% Potential Upside Amid Market Challenges 19 November 2025
Chrysalis Investments Limited (CHRY.L) Investor Outlook: Analyzing a 19% Potential Upside 19 November 2025